The “face of Ozempic” is the driving force behind the rapid increase in sales. face filleraccording to a major pharmaceutical company.
Flemming Ornskov, CEO of Swiss dermatology company Galderma, says: weight loss drugs Some people felt that it caused “facial sagging” and required cosmetic surgery to correct it.
People report that after losing weight their cheeks become hollow and the skin on their face becomes sagging, and this phenomenon has been labeled as “.Ozempic’s face”.
It has become so widespread that Galderma has reported a “significant increase” in the number of customers choosing products designed to: smooth wrinkles Restores youthful facial features.
“I think there has been a dramatic change in the look of ‘old people,'” Ornskov told the Financial Times.
Ozempic is self-administered with an injection pen – Carolina Ruda
“People are going to live another 10 to 15 years, and they want to be the way they feel, not the way they physically look if they didn’t take care of themselves.”
The company’s products are so popular that the company announced record profits last year, up nearly 10%.
Galderma offers injections to help replace lost collagen And it makes your skin look plump.
Ornskov said the weight loss drug was a big driver of sales as users sought the help of dermatologists to correct their “Ozempik face.”
“When you lose more than 8 to 10 kilograms, your face starts to look sagging,” he continued.
“You have to use filler there.”
He added that the company’s most popular filler was originally developed for HIV patients who were losing weight rapidly.
filler brand known as Sculptrahas launched a new product aimed at people who want to make their jawline look more beautiful, especially when it comes to men.
However, in 2023, TV personalities will sharon osbournethe 72-year-old spoke about the side effects of taking Ozempic, saying she now feels “too thin.”
Dr Anjali Mahato, a consultant dermatologist, previously told the Telegraph: dermal fillers Very effective in restoring lost volume and contouring the face. In particular, the cheeks and jawline are the most vulnerable areas. rapid weight loss.
“The rapid loss of subcutaneous fat accentuates fine lines and wrinkles, making the skin look older.”
Ozempic is a formulation of the drug semaglutide, which is used to treat type 2 diabetes, but is prescribed off-label for weight loss purposes.
A spokesperson for Novo Nordisk, the pharmaceutical company that makes Ozempic, said: “Novo Nordisk does not recognize the ‘Ozempic face’ as a safety concern or side effect of once-weekly use of semaglutide for type 2 diabetes. ” he said.
“Clinical data and postmarketing experience do not indicate these facial changes as adverse events for Ozempic, so they are not listed as potential side effects in the product’s prescribing information.
“Clinical studies completed to date have cumulatively exposed more than 25,000 participants to semaglutide for type 2 diabetes, oral semaglutide for type 2 diabetes, or semaglutide for weight management.
“Novo Nordisk recognizes that some healthcare providers may be prescribing Ozempic (semaglutide injection) to patients aiming to lose weight; We do not recommend, suggest or encourage any off-label use of our products and are committed to complying fully with all applicable laws and regulations in the promotion of our products.
